단백질 정제 및 분리 시장 보고서 : 기술별, 제품별, 용도별, 최종사용자별, 지역별(2026-2034년)

The global protein purification and isolation market size reached USD 10.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 22.1 Billion by 2034, exhibiting a growth rate (CAGR) of 7.64% during 2026-2034. The market is driven by considerable growth in the pharmaceutical industry, increasing need for new ligand identification, continual advancements in the production of purification kits, growing research initiatives in academic institutes for structural and functional proteomics, and the rising number of preclinical trials outsourced by drug development companies.

PROTEIN PURIFICATION AND ISOLATION MARKET ANALYSIS:

• Major Market Drivers: Some of the crucial market drivers are the rising demand for biopharmaceuticals, increasing investment in research and development activities, and advancements in protein purification technologies. Furthermore, the growing focus on personalized medicine and the need for high-quality biologics further drives the market. Additionally, the expansion of the biotechnology industry and the increasing prevalence of chronic diseases requiring targeted therapies are key factors contributing to the market's growth.
• Key Market Trends: Some of the major market trends include the adoption of automated and high-throughput purification systems, the development of novel purification techniques such as affinity chromatography, and the growing preference for single-use technologies. Furthermore, the increasing use of recombinant proteins and the focus on streamlining purification processes to enhance efficiency and reduce costs are also notable trends influencing the protein purification and isolation market overview.
• Geographical Trends: North America is the leading regional market due to the presence of a well-established biotechnology sector, significant investment in life sciences research, and favorable government initiatives supporting biopharmaceutical development. The region's robust healthcare infrastructure and the high adoption rate of advanced technologies further contribute to its dominance in the market.
• Competitive Landscape: Some of the key market players include Abcam plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Company, Merck KGaA, Norgen Biotek Corp., Promega Corporation, Purolite, Qiagen N.V., and Thermo Fisher Scientific Inc.
• Challenges and Opportunities: Some of the challenges in the market include the high cost of protein purification instruments and reagents, the complexity of purification processes, and the need for skilled professionals. However, opportunities lie in the growing demand for biopharmaceuticals in emerging markets, advancements in purification technologies, and the increasing focus on research and development in the life sciences sector.

PROTEIN PURIFICATION AND ISOLATION MARKET TRENDS:

R&D expansion and growing biologics demand

The increasing research and development in pharmaceutical and biotechnology companies, growing demand for biologics, rapid technological advancements in protein purification and isolation techniques, and escalating prominence of contract research organizations (CROs) are the major factors driving the growth of the market. The biotechnology and pharmaceutical companies are strongly focusing on R&D of biologics and other protein-based therapeutics which increases the purified proteins demand. Protein isolation and purification is an important step in drug development to explore the structure and function of the proteins. As a result, the protein purification and isolation demand is expected to increase with the growing prevalence of chronic diseases and rising demand for novel treatment options.

Rising government support and investments

Governments across the world are increasingly investing in R&D and launching measures to support the development and growth of the pharmaceutical and biotechnology sectors. They also have given additional benefits through tax breaks, grants, and investment-friendly policies, among other things. The pharmaceutical industry is a highly profitable market for protein purification and separation solutions due to large investments in the development of biomarker-specific compounds. Precise protein isolation, facilitated by substantial amounts of purified substrates, is a critical component in preclinical drug development, thereby contributing to a positive protein purification and isolation market outlook.

Emerging therapeutics and advanced technologies

The increasing significance of discovering new ligands, such as protein-based medicinal molecules, is a major factor driving market growth. Furthermore, rising demand for purification kits in rapid screen tests, a shift toward technologically advanced instrumentation for protein purification, growth in the proteomics market, and increased R&D in pharmaceutical and biotechnological fields are expected to drive the market growth. In addition, the market is benefiting from untapped growth market potential and protein therapies. This, in turn, is expected to contribute to the industry's expansion.

PROTEIN PURIFICATION AND ISOLATION MARKET SEGMENTATION:

Breakup by Technology:

• Ultrafiltration
• Precipitation
• Preparative Chromatography
  • Affinity Chromatography
  • Ion Exchange Chromatography
  • Reverse-Phase Chromatography
  • Hydrophobic Charge Induction Chromatography
  • Size Exclusion Chromatography
• Electrophoresis
  • Gel Electrophoresis
  • Isoelectric Focusing Electrophoresis
  • Capillary Electrophoresis
• Western Blotting
• Dialysis and Diafiltration
• Centrifugation

Preparative chromatography dominates the market

Preparative chromatography generated the highest revenue, accounting for the largest share of the protein purification and isolation market growth. Preparative chromatography is highly effective in separating and purifying large quantities of compounds, which is crucial for applications requiring high-purity products. Its versatility in handling various sample sizes and types contributes significantly to its prominence in the market. This technology is widely utilized across multiple industries, including pharmaceuticals, biotechnology, and chemicals. It is particularly valued in the pharmaceutical industry for the purification of drugs and biologics, making it a critical component in drug development and manufacturing processes. Ongoing advancements in preparative chromatography techniques, such as improvements in column technology and detection methods, have enhanced its efficiency and effectiveness. These innovations continue to drive its adoption and expand its application range.

Breakup by Product:

• Instruments
• Consumables
  • Protein Purification Kits
  • Protein Purification Reagents
  • Prepacked Columns
  • Protein Purification Resins
  • Magnetic Beads
  • Others

Consumables hold the largest share in the market

The consumables segment accounts for the largest market share. Consumables such as kits, reagents, columns, and beads are crucial for performing chromatography processes to purify and isolate proteins. This continuous demand drives a steady and substantial market share for consumables compared to more durable instruments. Among the consumables segment, the protein purification kits simplify the workflow, lower the risk of cross-contamination, and improve process efficiency. These kits are useful in high-throughput techniques or when working with several samples simultaneously. Compared to instruments, consumables generally involve lower initial investment costs. This affordability encourages regular purchasing and contributes to a higher share of this segment in the market, especially for smaller laboratories and research facilities.

Breakup by Application:

• Drug Screening
• Protein-Protein Interaction Studies
• Biomarker Discovery
• Target Identification
• Disease Diagnostics and Monitoring
• Protein Therapeutics

Protein-protein interaction studies hold the maximum share in the market

Protein-protein interaction is the largest revenue-generating application and is also expected to witness substantial growth over the forecast period. The rising adoption of these techniques for obtaining purified proteins and a growing number of research studies based on structural protein are contributing to the segment growth. Protein purification offers a controlled environment for studying protein-protein interaction. As researchers focus on finding protein interactions that are important in disease causes, the demand for precise and efficient protein separation technologies increases further.

Breakup by End User:

• Hospitals and Diagnostic Centers
• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• contract research organizations (CROs)

Academic research institutes hold the maximum share in the market

Academic medical institutes account for the largest market. Protein purification and isolation are vital processes for such research institutes to understand the structure, function, and interactions of proteins, that reinforce several biological processes. Academic research institutes are centers of intense research activity and innovation. They conduct numerous experiments and studies, necessitating a wide range of laboratory products and technologies. These institutions often receive substantial funding and grants for research projects. This financial support allows them to invest in advanced technologies, consumables, and instruments, contributing to their dominant market share.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest protein purification and isolation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for protein purification and isolation.

North America is substantially contributing to the protein purification and isolation market revenue, primarily due to the presence of a robust biotechnology and pharmaceutical industry. In line with this, substantial investments in research and development (R&D) activities are also acting as a major growth-inducing factor for the market. Furthermore, the region benefits from strong government support and favorable regulatory frameworks that encourage innovation and market expansion. The region's well-established healthcare infrastructure and high adoption rate of cutting-edge technologies further contribute to its market dominance. In addition to technological advancements, the region also sees significant protein purification and isolation market revenue, bolstered by the high demand for research in life sciences and the development of new therapeutic proteins. Moreover, the protein purification and isolation market forecast indicates that North America will continue to lead the market, driven by the increasing demand for biopharmaceuticals and the growing focus on personalized medicine.

COMPETITIVE LANDSCAPE:

• The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include Abcam plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Company, Merck KGaA, Norgen Biotek Corp., Promega Corporation, Purolite, Qiagen N.V., and Thermo Fisher Scientific Inc. ()
• Key players in the market are contributing to the growth of the market through continuous innovation and strategic initiatives. Prominent protein purification and isolation companies such as Abcam plc, Agilent Technologies Inc., and Thermo Fisher Scientific Inc. are investing heavily in research and development (R&D) to introduce advanced purification technologies. These innovations enhance the efficiency and accuracy of protein purification, catering to the growing demand for biopharmaceuticals and personalized medicine. Additionally, collaborations and partnerships between the key companies are fostering the development of more sophisticated and integrated solutions, further propelling market expansion. The rising adoption of automated systems and high-throughput technologies is also significantly impacting the protein purification and isolation market value. In addition to this, the leading players are focusing on expanding their product portfolios and improving their purification methods, with an emphasis on cost-effective and scalable purification processes for meeting the changing needs of the biotechnology and pharmaceutical industries. The incorporation of AI and machine learning into protein purification technologies is transforming the industry. Key players are investing in AI-driven solutions to optimize purification protocols, predict outcomes, and automate complex processes. This advancement is highlighted in the protein purification and isolation market research report, which showcases the significant impact of these technologies on enhancing efficiency and precision in the field.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How has the global protein purification and isolation market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global protein purification and isolation market?
• What is the impact of each driver, restraint, and opportunity on the global protein purification and isolation market?
• What are the key regional markets?
• Which countries represent the most attractive protein purification and isolation market?
• What is the breakup of the market based on technology?
• Which is the most attractive technology in the protein purification and isolation market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the protein purification and isolation market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the protein purification and isolation market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the protein purification and isolation market?
• What is the competitive structure of the market?
• Who are the key players/companies in the global protein purification and isolation market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Protein Purification and Isolation Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Technology

• 6.1 Ultrafiltration
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Precipitation
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Preparative Chromatography
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 Affinity Chromatography
    • 6.3.2.2 Ion Exchange Chromatography
    • 6.3.2.3 Reverse-Phase Chromatography
    • 6.3.2.4 Hydrophobic Charge Induction Chromatography
    • 6.3.2.5 Size Exclusion Chromatography
  • 6.3.3 Market Forecast
• 6.4 Electrophoresis
  • 6.4.1 Market Trends
  • 6.4.2 Key Segments
    • 6.4.2.1 Gel Electrophoresis
    • 6.4.2.2 Isoelectric Focusing Electrophoresis
    • 6.4.2.3 Capillary Electrophoresis
  • 6.4.3 Market Forecast
• 6.5 Western Blotting
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Dialysis and Diafiltration
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Centrifugation
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by Product

• 7.1 Instruments
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Consumables
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Protein Purification Kits
    • 7.2.2.2 Protein Purification Reagents
    • 7.2.2.3 Prepacked Columns
    • 7.2.2.4 Protein Purification Resins
    • 7.2.2.5 Magnetic Beads
    • 7.2.2.6 Others
  • 7.2.3 Market Forecast

8 Market Breakup by Application

• 8.1 Drug Screening
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Protein-Protein Interaction Studies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Biomarker Discovery
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Target Identification
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Disease Diagnostics and Monitoring
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Protein Therapeutics
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals and Diagnostic Centers
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Academic Research Institutes
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Pharmaceutical and Biotechnology Companies
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 contract research organizations (CROs)
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abcam plc
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Agilent Technologies Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Bio-Rad Laboratories Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 General Electric Company
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Merck KGaA
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Norgen Biotek Corp.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Promega Corporation
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Purolite
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Qiagen N.V.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Thermo Fisher Scientific Inc.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis